Neurogene Inc (NGNE)

Neurogene Inc (NGNE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $431M; returns 1 day -3.0%, 1 week +1.3%, 1 year -18.0%.

Neurogene Inc. is a clinical-stage biotechnology company specializing in the development of life-changing genetic medicines for patients and families affected by rare neurological diseases. The company currently generates minimal revenue as its products are still in development.

Groups NGNE belongs to

• Biotechnology
• Clinical Stage Biotech
• Gene Therapy
• Rare Diseases
• Neuroscience
• Neurological Disorders
• Rett Syndrome
• Healthcare
• Clinical Stage
• Healthcare Technology
• Precision Medicine
• Life Sciences

NGNE financial model: income statement, cash flow and balance sheet